T. Schrader et al.
FULL PAPER
[M +ꢀOMe], 236 (74) [M +]; ESI-HRMS: m/z: calcd for C12H17N2OP:
1.6 mmol, 92%). GC analyses (tR =14.5 min) did not show any unwanted
side products. 1H NMR (200 MHz, CDCl3): d=0.91 (t, 3J=8.5 Hz, 3H,
C(8)-H), 1.31–1.42 (m, 3H), 1.58–1.72 (m, 2H) 1.89–1.96 (m, 1H, C(3)-
H), 2.01–2.08 (m, 2H), 2.14–2.38 (m, 3H); 13C NMR (50 MHz, CDCl3):
d=11.0 (C(8)), 25.2 (C(7)), 29.2, 30.8, 40.6 (C(3)), 41.4, 47.7, 211.9
(C(1)).
236.1072, found 236.1072.
(1R,8S)-1-(a-Naphthoxy)-2-phenyl-2,7-diaza-1-phosphabicyclo[3.3.0]oc-
tane (6b): (S)-2-anilinomethylpyrrolidine (1.00 g, 5.71 mmol) was dis-
solved in anhydrous toluene (10 mL) under argon. After the addition of
NMR spectroscopic characterization of 2:1 and 1:1 ligand complexes
with CuI
Free ligand 5: 1H NMR (200 MHz, CDCl3): d=1.54–1.85 (m, 3H), 1.93–
2.05 (m, 1H), 2.60 (d, 3JH,P =8.7 Hz, 6H), 3.02–3.24 (m, 2H), 3.37–3.54
(m, 1H), 3.77 (ddd, J=1.0, 3JH,P =9.0, J=7.2 Hz, 1H, C(3)-H), 4.06–4.19
(m, 1H), 6.76 (tt, J=7.2, J=1.0 Hz, 1H), 6.84 (m, 2H), 7.21 (m, 2H);
31P NMR (81 MHz, CDCl3): d=119.3 (s).
CuI-ligand 5 (2:1, dissolved crystals): 1H NMR (200 MHz, CDCl3): d=
1.40–1.51 (m, 1H), 1.72–1.97 (m, 3H), 2.55 (s, 6H), 2.98–3.10 (m, 1H),
3.44 (t, J=8.6 Hz, 1H), 3.80–3.87 (m, 2H), 6.52 (d, J=6 Hz, 2H), 6.74 (t,
J=16 Hz, 1H), 7.10 (t, J=16 Hz, 2H); 31P NMR (81 MHz, CDCl3): d=
99.6 (brs); Dd(31P NMR)=20.3 ppm.
tris(dimethylamino)phosphine (0.99 g, 1.1 mL, 6.1 mmol, 1.1 equiv) the
mixture was heated to reflux for 4 h. The reaction was monitored by
31P NMR. After cooling to room temperature, the solvent and the excess
of tris(dimethylamino)phosphine were distilled off. The residue was dilut-
ed with anhydrous toluene (10 mL), treated with a-naphthol (0.88 g,
6.1 mmol, 1.1 equiv) and again heated to reflux. The solvent was distilled
off in vacuo. The remaining gum-like residue was subjected to fractional
distillation in a Kugelrohr apparatus (1.910ꢀ1 mbar, 2508C) to obtain
the title compound as a yellow gum (0.85 g, 2.4 mmol, 42.0%). 1H and
31P NMR spectra indicated a small impurity of (1R,8S)-1-(dimethyla-
mino)-2-phenyl-2,7-diaza-1-phosphabicyclo[3.3.0]octane (2) as well as a-
1
Free ligand 6a: H NMR (200 MHz, CDCl3): d=1.54–1.85 (m, 3H), 1.95–
2.08 (m, 1H), 3.08–3.25 (m, 2H), 3.33 (d, 3JH,P =8.5 Hz, 3H), 3.48–3.64
3
(m, 1H), 3.75 (ddd, J=1.0, JH,P =9.0, J=7.2 Hz, 1H), 4.10–4.22 (m, 1H),
6.83 (tt, J=7.2, J=1.0 Hz, 1H), 6.99–7.04 (m, 2H), 7.23 (m, 2H);
31P NMR (81 MHz, CDCl3): d=123.5 (s).
1
naphthol, which could not be completely eliminated. H NMR (200 MHz,
CDCl3): d=1.35–1.47 (m, 1H), 1.61–1.83 (m, 3H), 3.00–3.20 (m, 2H),
3.41–3.76 (m, 3H), 6.86–6.95 (m, 2H), 7.11 (m, 2H), 7.20–7.46 (m, 7H),
7.71 (m, 1H); 31P NMR (81 MHz, CDCl3): d=125.4 (s); 13C NMR
(50 MHz, CDCl3): d=26.4, 31.8, 47.3, 53.8, 62.7, 115.3, 115.6, 115.8, 119.6,
122.8, 123.1, 125.1, 125.8, 127.3, 128.4, 129.2, 145.2, 150.4.
CuI-ligand 6a (4.79 mg, 0.025 mmol, 1 equivCuI; 11.81 mg, 0.05 mmol,
2 equiv 6a): 1H NMR (200 MHz, CDCl3): d=1.52–1.75 (m, 2H), 1.76–
2.04 (m, 3H), 3.15 (t, J=8.7 Hz, 1H), 3.37–3.50 (brs, 3H), 3.62–3.86 (m,
2H), 3.87–3.99 (m, 1H), 6.84 (t, J=14 Hz, 1H), 7.02–7.27 (m, 4H);
31P NMR (81 MHz, CDCl3): d=104 (brs); Dd(31P NMR)=19.5 ppm.
(1R,7R)-4-N,N-Dimethylamino-9,9-dimethyl-2,2,6,6-tetraphenyl-3,5,8,10-
Free ligand 6b: 1H NMR (200 MHz, CDCl3): d=1.35–1.47 (m, 1H),
1.61–1.83 (m, 3H), 3.00–3.20 (m, 2H), 3.41–3.76 (m, 3H), 6.86–6.95 (m,
2H), 7.11 (m, 2H), 7.20–7.46 (m, 7H), 7.71 (m, 1H); 31P NMR (81 MHz,
CDCl3): d=125.4 (s).
tetraoxo-4-phosphabicyclo[5.3.0]decane
(8):
TADDOL
(10.0 g,
21.4 mmol) was dissolved under argon in dry chloroform (50.0 mL) and
HMPT (4.2 g, 4.7 mL, 25.7 mmol) was added dropwise with a syringe.
The mixture was heated to reflux for 12–16 h. After 2 h the product
begins to precipitate. At the end of the reaction the mixture is cooled to
room temperature and the product is filtered off, washed with dry chloro-
form and dried in vacuo to furnish pure phosphoramidite (8.5 g, 73%). A
second crop (2.0 g, 18%) of product was obtained after partial removal
of the solvent. The product can be recrystallized from chloroform or di-
chloromethane. 1H NMR (200 MHz, CDCl3): d=0.29 (s, 3H), 1.26 (s,
3H), 2.72 (d, 3JH,P =10.5 Hz, 6H), 4.82 (d, J=8.5 Hz, 1H), 5.18 (dd, J=
3.2, J=8.5 Hz, 1H), 7.16–7.33 (m, 12H), 7.41 (d, J=7.7 Hz, 2H), 7.47 (d,
J=7.5 Hz, 2H), 7.59 (d, J=7.7 Hz, 2H), 7.73 (d, J=7.5 Hz, 2H);
13C NMR (75 MHz, CDCl3): d=25.29 (q), 27.51 (q), 35.18 (q), 35.44 (q),
81.17 (d, JP,C =7.3 Hz), 81.81 (s), 82.35 (d, JP, C =23.2 Hz), 82.45 (d), 111.71
(s), 127.09 (d), 127.25 (d), 127.44 (d), 127.65 (d), 128.07 (d), 128.67 (d),
128.74 (d), 128.95 (d), 141.77 (s), 142.09 (s), 146.43 (s), 146.85 (s);
31P NMR (81 MHz, CDCl3): d=139.9 (s).
CuI-ligand 6b (3.81 mg, 0.02 mmol, 1 equivCuI; 13.95 mg, 0.04 mmol,
2 equiv 6b): 1H NMR (200 MHz, CDCl3): d=1.18–1.80 (m, 4H), 2.70–
2.91 (m, 2H), 2.92–3.07 (dd, J=7.8 Hz, 1H), 3.27–3.39 (dd, J=7.8 Hz,
1H), 4.00–4.19 (brs, 1H), 6.74–6.88 (m, 2H), 7.01–7.61 (m, 9H), 7.71–
7.78 (m, 1H), 8.22–8.33 (m, 1H) ; 31P NMR (81 MHz, CDCl3): d=96.5
(brs); Dd(31P NMR)=29.1 ppm.
3
Free ligand 7: 1H NMR (200 MHz, CDCl3): d=2.54 (d, JH,P =9 Hz, 6H),
7.18–7.51 (m, 7H), 7.87–7.98 (m, 4H); 31P NMR (81 MHz, CDCl3): d=
149 (s).
CuI-ligand 7 (3.05 mg, 0.016 mmol, 1 equivCuI; 11.46 mg, 0.032 mmol,
1
2 equiv 7): H NMR (200 MHz, CDCl3): d=2.26 (brs, 6H), 7.16–7.46 (m,
7H), 7.73–7.90 (m, 5H); 31P NMR (81 MHz, CDCl3): d=128 (brs);
Dd(31P NMR)=21 ppm.
1
Free ligand 8: H NMR (200 MHz, CDCl3): d=0.29 (s, 3H), 1.26 (s, 3H),
3
2.72 (d, JH,P =10.5 Hz, 6H), 4.82 (d, J=8.5 Hz, 1H), 5.18 (dd, J=3.2, J=
General procedure for the conjugate addition of diethylzinc to a,b-unsa-
turated carbonyl compounds: copper(ii)-bis(trifluoromethylsulfonate)
(6.0 mg, 1.7 mmol, 1 mol%) were stirred with two equivalents of the re-
spective ligand (3.4 mmol, 2 mol%) or its solution in toluene at room
temperature for 2 h. The solution was cooled to ꢀ308C and treated with
the respective enone (1.7 mmol) or its solution. After stirring for 30 min,
8.5 Hz, 1H), 7.16–7.33 (m, 12H), 7.41 (d, J=7.7 Hz, 2H), 7.47 (d, J=
7.5 Hz, 2H), 7.59 (d, J=7.7 Hz, 2H), 7.73 (d, J=7.5 Hz, 2H); 31P NMR
(81 MHz, CDCl3): d=139.9 (s).
CuI-ligand 8 (3.77 mg, 0.02 mmol, 1 equivCuI; 10.95 mg, 0,02 mmol,
1 equiv 8): 1H NMR (200 MHz, CDCl3): d=0.45–0.71 (brd, J=32.0 Hz,
6H), 2.49 (brd, J=11.3 Hz, 6H), 5.28 (brs, 2H), 7.17–7.36 (m, 11H),
7.37–7.46 (t, J=7.5 Hz, 4H), 7.50–7.66 (m, 6H); 31P NMR (81 MHz,
CDCl3): d=102.6 (s); Dd(31P NMR)=37.3 ppm.
a
diethylzinc 15% solution in hexanes (0.25 g, 2.2 mL, 2.2 mmol,
1.1 equiv) was added dropwise within 5 min, so that the reaction temper-
ature did not rise above ꢀ308C. After 16 h the solution was warmed to
08C and treated with 1n aqueous HCl. The resulting product was extract-
ed with diethyl ether; then the combined organic phases were washed
with satd aqueous NaHCO3 and subsequently with aqueous NaCl and
dried over MgSO4. After filtration, the solvent was removed in vacuo
and the crude product was purified by chromatography.
Note: The oxygen and water sensitivity of the ligands required perform-
ance of their weighing procedure and subsequent transfer into NMR
tubes inside a glove box.
Gas chromatography: Gaschromatographic analyses were carried out
with a Hewlett-Packard gaschromatograph (HP 5890 Series II) equipped
with FID and a Hewlett-Packard Integrator (HP 3396 Series II). The sta-
tionary phase was contained in a Supelco “g-Dex 120” column (30 m
0.25 mm0.25 mm). The same temperature program was used repeatedly
(start T = 808C (5 min), rate: 48Cminꢀ1, final T = 1408C (5 min) (nitro-
gen carrier gas).
3-Ethylcyclohexanone: The reaction was carried out with 2-cyclohexe-
none (0.16 mL, 0.16 g, 1.7 mmol). The reaction went to completion within
16 h with all ligands. The product was purified over silica gel eluting with
n-hexane/ethyl acetate 4:1 (Rf =0.40) to yield the title compound (0.24 g,
Kinetics of the 1,4-addition of diethylzinc to 2-cyclohexenone
a) Dependence on [enone]: 1m reference solutions were prepared from
2-cyclohexenone and cyclohexanone as internal GC standard in dry tolu-
6054
ꢁ 2004 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim
Chem. Eur. J. 2004, 10, 6048 – 6057